A phase Ib/II study of nanatinostat (Nstat) plus valganciclovir (VGCV) in EBV plus solid tumors and with pembrolizumab (PEM) in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC)

A. D. Colevas, L. Siu,D. W-T. Lim, B. Gao,P-J. Voon,S. Khan, L. Eng,M-J. Ahn, V. Lee, H. M. Wang,M-H. Yang, D. Bowles, R. Ferrarotto, A. Elguindy, A. Katkov, K. McGovern, B. Ma

ANNALS OF ONCOLOGY（2023）

引用 0|浏览2